A novel antagonist to the inhibitors of apoptosis (IAPs) potentiates cell death in EGFR-overexpressing non-small-cell lung cancer cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel antagonist to the inhibitors of apoptosis (IAPs) potentiates cell death in EGFR-overexpressing non-small-cell lung cancer cells
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 5, Issue 10, Pages e1477-e1477
Publisher
Springer Nature
Online
2014-10-16
DOI
10.1038/cddis.2014.447
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel antitumor activity of deguelin targeting the insulin-like growth factor (IGF) receptor pathway via up-regulation of IGF-binding protein-3 expression in breast cancer
- (2013) Young-Ah Suh et al. CANCER LETTERS
- Regulation of cell migration, invasion and metastasis by IAP proteins and their antagonists
- (2013) S Fulda ONCOGENE
- Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
- (2013) Rossana Berardi et al. OncoTargets and Therapy
- Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)
- (2012) John A. Flygare et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antitumor Activity and Pharmacodynamic Biomarkers of a Novel and Orally Available Small-Molecule Antagonist of Inhibitor of Apoptosis Proteins
- (2012) H. Sumi et al. MOLECULAR CANCER THERAPEUTICS
- Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC)
- (2011) C.P. Belani et al. CANCER TREATMENT REVIEWS
- A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment
- (2011) Qian Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Endogenous knockdown of survivin improves chemotherapeutic response in ALL models
- (2011) D J Morrison et al. LEUKEMIA
- Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
- (2011) Ronan J Kelly et al. Molecular Cancer
- Antagonists of IAP proteins as cancer therapeutics
- (2010) Jasmin N. Dynek et al. CANCER LETTERS
- Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice with Pancreatic Cancer
- (2010) Sean P. Dineen et al. CANCER RESEARCH
- Smac mimetics: implications for enhancement of targeted therapies in leukemia
- (2010) E Weisberg et al. LEUKEMIA
- Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer
- (2009) T. Yamada et al. CLINICAL CANCER RESEARCH
- Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma
- (2009) Krepela INTERNATIONAL JOURNAL OF ONCOLOGY
- The E3 Ubiquitin Ligase cIAP1 Binds and Ubiquitinates Caspase-3 and -7 via Unique Mechanisms at Distinct Steps in Their Processing
- (2009) Young Eun Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IAP-targeted therapies for cancer
- (2008) E C LaCasse et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started